Results 1 to 10 of about 3,032 (152)

Persistent Infections by Leishmania (Viannia) braziliensis [PDF]

open access: yesMemorias do Instituto Oswaldo Cruz, 1997
Here we review the phenomenon of persistency in Leishmania (Viannia) braziliensis infections. In other Leishmania species where appropriate animal models exist, considerable advances in the understanding of basic immunologic mechanisms of persistency ...
José Luis Ramírez, Palmira Guevara
doaj   +3 more sources

The activity of azithromycin against Leishmania (Viannia) braziliensis and Leishmania (Leishmania) amazonensis in the golden hamster model A atividade da azitromicina contra a Leishmania (Viannia) braziliensis e a Leishmania (Leishmania) amazonensis no modelo golden hamster [PDF]

open access: yesRevista da Sociedade Brasileira de Medicina Tropical, 2007
New therapeutic alternatives against leishmaniasis remain a priority. The activity of azithromycin against Leishmania (Leishmania) major has been previously demonstrated.
Ángel Sinagra   +5 more
doaj   +5 more sources

Genomic Diversification, Structural Plasticity, and Hybridization in Leishmania (Viannia) braziliensis. [PDF]

open access: yesFront Cell Infect Microbiol, 2020
Leishmania (Viannia) braziliensis es una especie importante de Leishmania que circula en varios países de América Central y del Sur. Entre las especies de Leishmania que circulan en Brasil, Argentina y Colombia, L. braziliensis tiene la mayor variabilidad genómica.
Patino LH   +4 more
europepmc   +5 more sources

Genetic diversity and population structure of Leishmania (Viannia) braziliensis in the Peruvian jungle. [PDF]

open access: yesPLoS Negl Trop Dis, 2022
Background Human cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis is highly prevalent in the Peruvian jungle, where it affects military forces deployed to fight against drug trafficking and civilian people that migrate from the highland to the lowland jungle for economic activities such as mining, agriculture, construction, and ...
De Los Santos MB   +4 more
europepmc   +6 more sources

Effective Genome Editing in Leishmania (Viannia) braziliensis Stably Expressing Cas9 and T7 RNA Polymerase [PDF]

open access: yesFrontiers in Cellular and Infection Microbiology, 2021
Until 2015, loss-of-function studies to elucidate protein function in Leishmania relied on gene disruption through homologous recombination. Then, the CRISPR/Cas9 revolution reached these protozoan parasites allowing efficient genome editing with one ...
Caroline R. Espada   +12 more
doaj   +2 more sources

Is Leishmania (Viannia) braziliensis parasite load associated with disease pathogenesis? [PDF]

open access: yesInternational Journal of Infectious Diseases, 2017
Leishmania (Viannia) braziliensis is the main etiological agent of tegumentary leishmaniasis in the Americas. Parasite molecular diversity and host immune status contribute to extensive variations in its clinical presentation within endemic areas of Brazil.
Claude Pirmez
exaly   +4 more sources

Leishmania (Viannia) braziliensis type 2 as probable etiological agent of canine cutaneous leishmaniasis in Brazilian Amazon. [PDF]

open access: yesPLoS ONE, 2019
Canine cutaneous leishmaniasis (CCL) is a zoonosis of public health interest, and in the Americas, Leishmania (Viannia) braziliensis has been identified as the main etiological agent. The present study sought to investigate Leishmania spp.
Andreia Fernandes Brilhante   +11 more
doaj   +2 more sources

Chemotaxis in Leishmania (Viannia) braziliensis: Evaluation by the two-chamber capillary assay. [PDF]

open access: yesMethodsX, 2021
Chemotactic responses play a significant role during Leishmania (V.) braziliensis differentiation through its life cycle and during infection. The aim of this description has been to portray the modified "two-chamber capillary chemotaxis assay" as a technique useful for quantitative in vitro evaluation of Leishmania chemotaxis after reviewing the ...
López ED   +5 more
europepmc   +6 more sources

Mucosal Leishmaniasis Caused by Leishmania (Viannia) braziliensis and Leishmania (Viannia) guyanensis in the Brazilian Amazon

open access: yesPLoS Neglected Tropical Diseases, 2011
Leishmania (Viannia) braziliensis is a parasite recognized as the most important etiologic agent of mucosal leishmaniasis (ML) in the New World. In Amazonia, seven different species of Leishmania, etiologic agents of human Cutaneous Leishmaniasis, have been described. Isolated cases of ML have been described for several different species of Leishmania:
Jorge Guerra   +2 more
exaly   +5 more sources

Leishmania (Viannia) braziliensis em cães naturalmente infectados Leishmania (Viannia) braziliensis in naturally infected dogs

open access: yesRevista da Sociedade Brasileira de Medicina Tropical, 2003
Foram estudados oito cães provenientes do Município de Maricá (RJ), com lesões sugestivas de leishmaniose tegumentar americana por métodos parasitológicos e sorológicos. Leishmania spp foi encontrada em seis cães através do cultivo in vitro.
Maria de Fátima Madeira   +6 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy